Factors Tied to Molecular Testing by Dermatopathologists ID'd

Share this content:
Factors Tied to Molecular Testing by Dermatopathologists ID'd
Factors Tied to Molecular Testing by Dermatopathologists ID'd

MONDAY, Feb. 26, 2018 (HealthDay News) -- Among dermatopathologists, relevant instruction during residency training, primary board certification in pathology, and academic medical center affiliation are among the factors associated with more frequent utilization of molecular testing, according to a study published online Feb. 13 in the Journal of Cutaneous Pathology.

Kristin Torre, from the University of Connecticut in Farmington, and colleagues surveyed 136 dermatopathologists to learn how they are employing molecular testing for neoplastic skin diseases and to assess their opinions of the broader role and utility of molecular technologies in clinical practice. The 15-question survey was sent to fellows of the American Society of Dermatopathology.

The researchers found that the vast majority of respondents (94 percent) reported experience with at least one molecular testing strategy. Nearly two in three dermatopathologists (62 percent) order ≥12 molecular tests per year, while 5 percent report ordering two or fewer assays per year. Factors associated with more frequent utilization of molecular testing include relevant instruction during residency training, primary board certification in pathology, academic medical center affiliation, higher-volume clinical practice, presence of on-site clinical molecular pathology/cytogenetics laboratory, and greater physician confidence incorporating test results into histopathological assessments.

"Wider adoption of molecular testing in dermatopathology may be limited by factors such as physician training, test costs/insurance coverage, logistical issues, and lack of evidence-based clinical practice guidelines," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »